Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 14, 2001

View Archived Issues

Bentley and Pfizer enter R&D agreement for enhanced drug delivery

Patient enrollment completed for phase II study of IPL-576092 in mild asthma

FDA approves Herceptin labeling changes to add survival data

Orphan drug status awarded to bryostatin 1 for combination therapy of esophageal cancer

Approvable letter expands use and formulations of Vivelle-Dot

Replacement therapy for congenital protein C deficiency now available in Europe

Relief of oral mucositis pain on iseganan correlated with other outcome measures

Efficacy of ARGENT-Epo regulated gene expression therapy demonstrated in mouse model

Successful repeated administration of MaxAdFVIII achieved in animal studies

Interneuron highlights positive year-end developments

First human study demonstrates safety of heparin/SNAD and potential efficacy

Humanized anti-HM1.24 MAb well tolerated in phase I trial in myeloma patients

Combination therapy with Myocet and Herceptin safe and effective in advanced breast cancer

Neurochem continues to build on success to date

Effects of new SERM on breast cancer and bone turnover biomarkers in women

Pregabalin safe and well tolerated as add-on therapy of partial seizures

Encouraging results from phase I/II trial of novel narcotic painkiller PTI-801

FDA gives go-ahead for HuMax-CD4 phase III trial in rheumatoid arthritis

SkyePharma and Astralis sign agreements for Psoraxine

Sankyo and Forest to copromote Benicar in U.S. for treatment of hypertension

Synergistic anticancer combinations identified at Schering-Plough

Tularik discovers new series of HCV polymerase inhibitors

Antitumor anthrapyridones claimed by Nippon Kayaku

Na+/K+-ATPase inhibitors and their use described by Yissum

ADIR scientists synthesize vitronectin receptor antagonist series

Idun presents new ICE/ced-3 inhibitors

Antiviral compounds targeting viral reverse transcriptase described by Dong Wha

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026